HeartsciencesHSCS

13F holders, Q2 2025 (June 30)
7holders +2
4new positions
2sold out
1famous investor
$3.65avg. 13F price*

At the end of Q2 2025, 7 institutions reported holding Heartsciences Inc. (HSCS) in their 13F filings, up 2 from Q1 2025. 4 opened new positions and 2 sold out. The largest holders were Astoria Strategic Wealth, Inc. ($71K), Citadel Advisors ($70K) and Geode Capital Management, LLC ($43K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Heartsciences Inc.
CUSIP
42254E302
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q2 2024: 7Q2 2024Q3 2024: 6Q3 2024Q4 2024: 3Q4 2024Q1 2025: 5Q1 2025Q2 2025: 7Q2 2025Q3 2025: 12Q3 2025Q4 2025: 10Q4 2025Q1 2026: 13Q1 2026Q2 2026: 16Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions4$146K
Exits2$9K

All 13F filers, Q1 2025 → Q2 2025: 40,684 shares bought and 3,893 shares sold, net +36,791 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

Astoria Strategic Wealth, Inc. 0.02% No change 18,927 $71K
Citadel Advisors 0.00% New 18,684 $70K
Geode Capital Management, LLC 0.00% New 11,599 $43K
Advisory Services Network, LLC 0.00% New 10,000 $31K
Tower Research Capital LLC (TRC) 0.00% Reduce -51.9% 665 $2K
Federation des caisses Desjardins du Quebec 0.00% New 400 $2K
Bank of America Corp. 0.00% Add +11.1% 10 $38

"% of holder's portfolio" is HSCS's weight in each manager's 13F, not the share of Heartsciences Inc. the manager owns.